Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Crispr Pioneers Win 2020 Nobel Prize for Chemistry



Farhud DD1, 2, 3 ; Zarifyeganeh M3, 4
Authors

Source: Iranian Journal of Public Health Published:2020

Abstract

Over the last few years, the development of genome editing has revolutionized research on the human genome. Recent advances in developing programmable nucleases, such as meganucleases, ZFNs, TALENs and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas, has greatly expedited the progress of gene editing from concept to clinical practice. The CRISPR has advantages over other nuclease-based genome editing tools due to its high accuracy, efficiency, and strong specificity. Eight years after CRISPR application for human genome edition by Emmanuelle Charpentier and Jennifer A. Doudna, the 2020 Nobel Prize in Chemistry has been jointly given to them for development of CRISPR-Cas9 gene editing, allows scientists to precisely cut and edit of DNA. © 2020, Iranian Journal of Public Health. All rights reserved.
Related Docs
View other Related Docs
1. Implications of Crispr-Cas9 Genome Editing Methods in Atherosclerotic Cardiovascular Diseases, Current Problems in Cardiology (2023)
2. Nanoparticles-Mediated Crispr/Cas9 Delivery: Recent Advances in Cancer Treatment, Journal of Drug Delivery Science and Technology (2020)
3. The Crispr Growth Spurt: From Bench to Clinic on Versatile Small Rnas, Journal of Microbiology and Biotechnology (2017)
Experts (# of related papers)
View all Related Experts
Fatemeh Radmanesh (2)
Gholamali Kardar (2)
Other Related Docs
4. Crispr-Cas9 in Basic and Translational Aspects of Cancer Therapy, BioImpacts (2024)
5. Technology Developments in Biological Tools for Targeted Genome Surgery, Biotechnology Letters (2015)
6. Crispr-Interceded Cho Cell Line Development Approaches, Biotechnology and Bioengineering (2023)
7. Applications of Innovation Technologies for Personalized Cancer Medicine: Stem Cells and Gene-Editing Tools, ACS Pharmacology and Translational Science (2023)
8. Advancing Mesenchymal Stem Cell Therapy With Crispr/Cas9 for Clinical Trial Studies, Advances in Experimental Medicine and Biology (2020)
9. The Conspicuity of Crispr-Cpf1 System As a Significant Breakthrough in Genome Editing, Current Microbiology (2018)
10. Smart Strategies for Precise Delivery of Crispr/Cas9 in Genome Editing, ACS Applied Bio Materials (2022)
11. Crispr/Cas System: A Powerful Strategy to Improve Monogenic Human Diseases As Therapeutic Delivery; Current Applications and Challenges, Current Gene Therapy (2025)
12. Therapeutic Applications of Crispr/Cas9 System in Gene Therapy, Biotechnology Letters (2018)
13. Exploring Non-Viral Methods for the Delivery of Crispr-Cas Ribonucleoprotein to Hematopoietic Stem Cells, Stem Cell Research and Therapy (2024)
14. Highly Photoluminescent Nitrogen- and Zinc-Doped Carbon Dots for Efficient Delivery of Crispr/Cas9 and Mrna, Bioconjugate Chemistry (2021)
15. Targeting Mrna-Coding Genes in Prostate Cancer Using Crispr/Cas9 Technology With a Special Focus on Androgen Receptor Signaling, Cell Communication and Signaling (2024)
16. Saponin and Fluorine-Modified Polycation As a Versatile Gene Delivery System, Nanotechnology (2022)
17. The Significance of Bioengineered Nanoplatforms Against Sars-Cov-2: From Detection to Genome Editing, Life Sciences (2021)
18. The Trend of Crispr-Based Technologies in Covid-19 Disease: Beyond Genome Editing, Molecular Biotechnology (2023)
19. Synthesis and Characterization of Vitamin D3-Functionalized Carbon Dots for Crispr/Cas9 Delivery, Nanomedicine (2021)
20. Crispr Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential, Cell Proliferation (2025)